Navigation Links
AtheroGenics Reports ARISE Trial Results for AGI-1067

rk may take a significant period of time to complete or require significant additional resources to complete, or that AstraZeneca could terminate its collaboration agreement with us based on the results of the clinical trial. We cannot ensure that AGI-1067 will ever be approved or be proven safe and effective for use in humans. These and other risks are discussed in AtheroGenics' Securities and Exchange Commission filings, including, but not limited to, the risks discussed in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006. The risk factors regarding AtheroGenics that are included under the caption "Risk Factors" in AtheroGenics' Annual Report on Form 10-K for the fiscal year ended December 31, 2006 are specifically incorporated by reference into this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


AtheroGenics, Inc.

Mark P. Colonnese

Chief Financial Officer

678-336-2511

Email Contact


Media Inquiries

Jayme Maniatis

Schwartz Communications, Inc.

781-684-0770 ext. 6610

Email Contact


Investor Inquiries

Lilian Stern

Stern Investor Relations, Inc.

212-362-1200

Email Contact

'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AtheroGenics Reports ARISE Trial Results for AGI
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
(Date:11/30/2008)...- Abnormalities in auditory and language processin...m disorder by using magnetoencephalography (MEG), ... meeting of the Radiological Society of North Amer...he tiny magnetic fields associated with electrical...e chair of research in the Department of Radiology...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...ewswire/ -- Proteolix, Inc., a,leader in the disc...arget,protein degradation pathways in cancer and ...om two ongoing Phase 2 clinical trials of carfilzo...upcoming 50th Annual Meeting of the,American Soci... in a new class,of specific proteasome inhibitors...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 1New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 1Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 3Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 1Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 1bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 3
...RD, Calif.--(BUSINESS WIRE)--Jul 5, 2007 - Scienti...ed so many suspects and,found so many treatments w...s an enigma. Now researchers at the Stanford,Unive...ing,principle that could explain how a range of ca... found that in rats the differing mechanisms of de...
...III clinical trial provides hope that HIV patients... 2007 /PRNewswire/ -- A new,investigational drug u...roven to be effective in fighting drug-resistant H...in its July 7th,special HIV/AIDS issue. , The mult... 18,nations and more than 30 centers in the United...
Other Medicine Technology:Stanford Researchers Find Brain Pathway of Depression in Rats 2Stanford Researchers Find Brain Pathway of Depression in Rats 3Stanford Researchers Find Brain Pathway of Depression in Rats 4New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 2New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 3
(Date:12/2/2008)...swire/ -- TYRX, Inc., a leader in the development ...oducts, today announced the appointment of David E... for commercial operations. , , Mr. Elliot ...device industry. Mr. Elliot joins TYRX from Valam ...ng laser-based antimicrobial and vascular plaque d...
(Date:12/2/2008)...ire/ -- BioIQ , the leader in consumer-friendly h... , who provides services that include wellness, he... care management as well as case management of acu...ployers, and government agencies, will work togeth...orting tools as part of Alere,s Personal Health So...
(Date:12/2/2008)...s form an integral part of most of,original equip...fore become,essential for service providers in th...ain competitive and constantly improve their servi...o: http://www.newscom.com/cgi-bin/prnh/20081117/...llivan ( http://www.medicalimaging.frost.com ),Eu...
(Date:12/2/2008)...lect and disseminate pharmacy experience and knowl...(PRWEB) December 2, 2008 -- Pharmacy OneSource, I...e to focus public and industry attention on medic...SPEAK will occur during the American Society of He...al Meeting, to be held December 7-11 in Orlando, F...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2
...ts in Britain have said that The World Bank did no...bly to keep up the promised sum of $500 million// ...o have manipulated data, with no adequate infrastr... of such a magnitude, reach completion. It is also...
...orities have declared that they will be launching ...curb infant and child deaths. This emergency vacci... and aims to protect nearly thousands of children ...s and five years. Nearly 1,600 cases of measles h...
...y done on 179 stroke patients, it was found that t... damage when they had stroke. The three drug// a c...tor for blood pressure control, and a cholesterol-...rk synergistically to reduce the amount of brain t...
... suggested that women who drink insufficient milk ...due to concerns about allergies may inhibit// thei...study were pubished in the Canadian Medical Associ...e study. All were non-smokers. However, on compari...
Other Medicine News:Health News:Limiting milk can hamper Babies’ Growt 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: